This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dentsply Sirona Inc (XRAY)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 2.67B 2.92B 2.95B 2.93B
Cost of Sales 1.02B 1.19B 1.24B 1.24B
Gross Operating Profit 1.65B 1.73B 1.71B 1.69B
Selling, General, and Administrative Expenses 1.08B 1.14B 1.14B 1.15B
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 574.10M 590.37M 565.41M 543.90M
Depreciation & Amortization 134.20M 133.68M 132.89M 136.24M
Interest Income 2.20M 5.59M 8.12M 8.76M
Other Income - Net 6.60M -249.00K -7.35M -6.44M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 384.00M 450.94M 419.94M 384.26M
Interest Expense 55.90M 46.91M 49.62M 56.85M
Pre-Tax Income 328.10M 404.03M 370.31M 327.41M
Income Taxes 77.00M 81.12M 52.15M 8.92M
Minority Interest -100.00K 59.00K 4.97M 4.28M
Net Income From Continuing Operations 251.10M 322.91M 318.16M 318.49M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 251.10M 322.91M 318.16M 318.49M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 251.20M 322.85M 313.19M 314.21M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
315.80M 334.00M 331.52M 344.21M
Preferred Dividends
Net Income Available To Common 251.10M 322.91M 318.16M 318.49M
Basic EPS from Continuing Ops. 1.79 2.28 2.20 2.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.79 2.28 2.20 2.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.79 2.28 2.20 2.22
Basic Normalized Net Income/Share 2.26 2.36 2.29 2.39
EPS fr Continuing Ops. 1.76 2.24 2.16 2.18
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.76 2.24 2.16 2.18
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.76 2.24 2.16 2.18
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.22 2.32 2.25 2.36
Dividends Paid per Share 0.29 0.27 0.25 0.22
XRAY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

XRAY Dentsply Sirona Inc

Chart of XRAY

Analysts Ratings for XRAY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 5 6
Moderate Buy 0 0 1 1
Hold 5 5 3 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET XRAY ANALYST REPORT

XRAY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs